Documented AI implementations for aI for target identification, molecular simulation, lead optimization, and accelerating the drug development pipeline. in medicine, with reported results where available.
AI drug discovery — target to Phase 1 in under 30 months
Drug Discovery
AI-powered drug discovery platform that identified a novel target (TNIK) for idiopathic pulmonary fibrosis and advanced a drug candidate from target identification to Phase 1 clinical trials in under 30 months — a process that traditionally takes 4-6 years. Phase 2a results published in Nature Medicine.
